Pregled bibliografske jedinice broj: 195582
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe // Clinical microbiology and infection, 8 (2002), 7; 388-396 doi:10.1046/j.1469-0691.2002.00435.x (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 195582 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe
Autori
Boyanova, L. ; Mentis, A. ; Gubina, M. ; Rozynek, E. ; Gosciniak, G. ; Kalenić, Smilja ; Goral, V. ; Kupcinskas, L. ; Kantarceken, B. ; Aydin, A. ; Archimandritis, A. ; Dzierzanowska, D. ; Včev, A. ; Ivanova, K. ; Marina, M. ; Mitov, I. ; Petrov, P. ; Ozden, A. ; Popova, M.
Izvornik
Clinical microbiology and infection (1198-743X) 8
(2002), 7;
388-396
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
helicobacter pylori ; antimicrobial resistance ; eastern Europe.
Sažetak
OBJECTIVE: To evaluate the primary, secondary and combined resistance to five antimicrobial agents of 2340 Helicobacter pylori isolates from 19 centers in 10 countries in eastern Europe. METHODS: Data were available for centers in Bulgaria, Croatia, the Czech Republic, Estonia, Greece, Lithuania, Poland, Russia, Slovenia and Turkey. Susceptibility was tested by agar dilution (seven countries), E test (five countries) and disk diffusion (three countries) methods. Resistance breakpoints (mg/L) were: metronidazole 8, clarithromycin 1, amoxicillin 0.5, tetracycline 4, and ciprofloxacin 1 or 4 in most centers. Primary and post-treatment resistance was assessed in 2003 and 337 isolates respectively. Results for 282 children and 201 adults were compared. RESULTS: Primary resistance rates since 1998 were: metronidazole 37.9%, clarithromycin 9.5%, amoxicillin 0.9%, tetracycline 1.9%, ciprofloxacin 3.9%, and both metronidazole and clarithromycin 6.1%. Isolates from centers in Slovenia and Lithuania exhibited low resistance rates. Since 1998, amoxicillin resistance has been detected in the southeastern region. From 1996, metronidazole resistance increased significantly from 30.5% to 36.4%, while clarithromycin resistance increased slightly from 8.9% to 10.6%. In centers in Greece, Poland, and Bulgaria, the mean metronidazole resistance was slightly higher in adults than in children (39% versus 31.2%, P > 0.05) ; this trend was not found for clarithromycin or amoxicillin (P > 0.20). Post-treatment resistance rates exhibited wide variations. CONCLUSIONS: In eastern Europe, primary H. pylori resistance to metronidazole is considerable, and that to clarithromycin is similar to or slightly higher than that in western Europe. Resistance to amoxicillin, ciprofloxacin and tetracycline was detected in several centers. Primary and post-treatment resistance rates vary greatly between centers.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada doi onlinelibrary.wiley.com www.sciencedirect.comCitiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Index Medicus